Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Immunogen Inc (IMGN)

Immunogen Inc (IMGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Immunogen Inc 830 WINTER ST WALTHAM MA 02451 USA

P: 781-895-0600

Description:

ImmunoGen, Inc. develops pharmaceuticals, primarily for the treatment of cancer. The company's product candidates are called tumor-activated prodrugs and are based on its proprietary immunoconjugate technology platform. Unlike conventional chemotherapeutic agents, tumor-activated prodrugs are intended to deliver potent chemotherapy specifically to a tumor. Each tumor-activated drug immunoconjugate comprises a small-molecule drug which has been chemically linked to a monoclonal antibody.

Key Statistics

Overview:

Market Capitalization, $K 1,200,262
Shares Outstanding, K 202,405
Annual Sales, $ 132,300 K
Annual Net Income, $ -44,370 K
Last Quarter Sales, $ 16,950 K
Last Quarter Net Income, $ -30,740 K
60-Month Beta 1.33
% of Insider Shareholders 3.09%
% of Institutional Shareholders 89.18%
Float, K 196,151
% Float 96.91%

Growth:

1-Year Return 55.64%
3-Year Return -37.38%
5-Year Return 121.27%
5-Year Revenue Growth 120.50%
5-Year Earnings Growth 64.79%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.15 on 07/30/21
Next Earnings Date N/A
Earnings Per Share ttm -0.29
EPS Growth vs. Prev Qtr 11.76%
EPS Growth vs. Prev Year -7.14%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

IMGN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -8.19
Price/Earnings to Growth N/A
Return-on-Equity % -106.62%
Return-on-Assets % -17.84%
Profit Margin % -33.54
Net Margin % -301.86
Debt/Equity 0.00
Price/Sales 8.77
Price/Cash Flow N/A
Price/Book 17.79
Book Value/Share 0.34
Interest Coverage -0.91
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar